Skip to Main Content

Paper Details

Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma.
Journal of the American College of Surgeons
7
2022
CDKN2A, FOLFIRINOX, KRAS, Localized Pancreatic Ductal Adenocarcinoma, PDAC, Patients, SMAD4, Somatic Driver Genes, TP53, fluorouracil, irinotecan, leucovorin, oxaliplatin, pancreatic ductal adenocarcinoma, patients
Author NameAffiliation
Mithat GonenMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2